Your browser doesn't support javascript.
loading
Microarray genómico prenatal: estudio de una cohorte de 393 casos / Prenatal genomic microarray: study of a cohort of 393 cases
Torrell, Núria; Grande, Maribel; Borobio, Virginia; Rodríguez-Revenga, Laia; Borrell, Antoni.
Affiliation
  • Torrell, Núria; Hospital Clinic de Barcelona. Barcelona. España
  • Grande, Maribel; Hospital Clinic de Barcelona. Barcelona. España
  • Borobio, Virginia; Hospital Clinic de Barcelona. Barcelona. España
  • Rodríguez-Revenga, Laia; Hospital Clinic de Barcelona. Centre Diagnòstic Biomèdic. Barcelona. España
  • Borrell, Antoni; Hospital Clinic de Barcelona. Barcelona. España
Prog. obstet. ginecol. (Ed. impr.) ; 60(5): 432-437, sept.-oct. 2017. tab
Article in Spanish | IBECS | ID: ibc-167325
Responsible library: ES1.1
Localization: BNCS
RESUMEN

Objetivos:

evaluar el rendimiento incremental del análisis de microarrays genómicos sobre cariotipado convencional en nuestra serie de microarrays prenatales.

Métodos:

393 mujeres embarazadas sometidas a un diagnóstico prenatal invasivo debido a malformaciones fetales, aumento de la translucencia nucal o restricción del crecimiento fetal de inicio temprano entre febrero de 2012 y agosto de 2015, a quienes se les ofreció realizar un análisis de microarrays genómicos y aceptaron.

Resultados:

el rendimiento de diagnóstico incremental sobre cariotipado convencional fue del 3,6% (IC del 95% 1,7-5,5). Esta tasa aumentó a 4,7% (95% IC 1,7-7,7) en anomalías estructurales aisladas.

Conclusiones:

el microarray genómico proporciona un rendimiento incremental del 3,6% sobre el cariotipado convencional en fetos con anomalías de ultrasonido y otras indicaciones específicas (AU)
ABSTRACT

Objectives:

To assess the incremental yield of genomic microarray analysis over conventional karyotyping in our series of prenatal microarrays.

Methods:

393 pregnant women undergoing an invasive prenatal diagnosis due to fetal malformations, increased nuchal translucency or early onset fetal growth restriction between February 2012 and August 2015, were offered and accepted to perform a genomic microarray analysis.

Results:

The incremental diagnostic yield over conventional karyotyping was 3.6% (95% CI 1.7-5.5). This rate increased to 4.7% (95% CI 1.7-7.7) in isolated structural anomalies.

Conclusions:

Genomic microarray provides a 3.6% incremental yield over conventional karyotyping in fetuses with ultrasound anomalies and other specific indications (AU)
Subject(s)
Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Prenatal Diagnosis / Oligonucleotide Array Sequence Analysis / Nuchal Translucency Measurement / Microarray Analysis / Fetal Development Type of study: Diagnostic study / Etiology study / Incidence study / Observational study / Risk factors Limits: Female / Humans / Pregnancy Language: Spanish Journal: Prog. obstet. ginecol. (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Clinic de Barcelona/España
Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Prenatal Diagnosis / Oligonucleotide Array Sequence Analysis / Nuchal Translucency Measurement / Microarray Analysis / Fetal Development Type of study: Diagnostic study / Etiology study / Incidence study / Observational study / Risk factors Limits: Female / Humans / Pregnancy Language: Spanish Journal: Prog. obstet. ginecol. (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Clinic de Barcelona/España
...